Recombinant multi-species LDHA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine LDHA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene catalyzes the conversion of L-lactate and NAD to pyruvate and NADH in the final step of anaerobic glycolysis. The protein is found predominantly in muscle tissue and belongs to the lactate dehydrogenase family. Mutations in this gene have been linked to exertional myoglobinuria. Multiple transcript variants encoding different isoforms have been found for this gene. The human genome contains several non-transcribed pseudogenes of this gene. [provided by RefSeq, Sep 2008]
The Alternative Names of target: CDK1,Cell proliferation-inducing gene 19 protein,GSD11,HEL-S-133P,L-lactate dehydrogenase A chain,LDH muscle subunit (LDH-M),LDH-A,LDHA,LDHM,Ldh1,Ldha,Ldhm,PIG19,Renal carcinoma antigen NY-REN-59,l7R2
Go
to LDHA products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T15053-Ag-1/ GM-Tg-hg-T15053-Ag-2 | Human LDHA protein | Human |
| GM-Tg-rg-T15053-Ag-1/ GM-Tg-rg-T15053-Ag-2 | Rat LDHA protein | Rat |
| GM-Tg-mg-T15053-Ag-1/ GM-Tg-mg-T15053-Ag-2 | Mouse LDHA protein | Mouse |
| GM-Tg-cynog-T15053-Ag-1/ GM-Tg-cynog-T15053-Ag-2 | Cynomolgus/Rhesus macaque LDHA protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T15053-Ag-1/ GM-Tg-felg-T15053-Ag-2 | Feline LDHA protein | Feline |
| GM-Tg-cang-T15053-Ag-1/ GM-Tg-cang-T15053-Ag-2 | Canine LDHA protein | Canine |
| GM-Tg-bovg-T15053-Ag-1/ GM-Tg-bovg-T15053-Ag-2 | Bovine LDHA protein | Bovine |
| GM-Tg-equg-T15053-Ag-1/ GM-Tg-equg-T15053-Ag-2 | Equine LDHA protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T15053-Ag-1/ GM-Tg-hg-T15053-Ag-2;
GM-Tg-rg-T15053-Ag-1/ GM-Tg-rg-T15053-Ag-2;
GM-Tg-mg-T15053-Ag-1/ GM-Tg-mg-T15053-Ag-2; GM-Tg-cynog-T15053-Ag-1/ GM-Tg-cynog-T15053-Ag-2; GM-Tg-felg-T15053-Ag-1/ GM-Tg-felg-T15053-Ag-2; GM-Tg-cang-T15053-Ag-1/ GM-Tg-cang-T15053-Ag-2; GM-Tg-bovg-T15053-Ag-1/ GM-Tg-bovg-T15053-Ag-2; GM-Tg-equg-T15053-Ag-1/ GM-Tg-equg-T15053-Ag-2 |
| Products Name | LDHA protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | LDHA |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine LDHA protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.